China approves human trial of Covid vaccines produced from insect cells | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Wednesday
May 28, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
WEDNESDAY, MAY 28, 2025
China approves human trial of Covid vaccines produced from insect cells

Coronavirus chronicle

UNB/Xinhua
26 August, 2020, 01:45 pm
Last modified: 26 August, 2020, 01:51 pm

Related News

  • Mango exports to China begins tomorrow
  • Weak Chinese demand leaves Australia with too much wheat
  • China explores cross-border trade cooperation with Bangladesh
  • Govt plans to relocate country's first vaccine plant from Gopalganj to Munshiganj
  • Dhaka, Beijing seek to resolve deadlock over dollar loan terms at JEC talks

China approves human trial of Covid vaccines produced from insect cells

The vaccine is designed to trigger antibodies against specific areas on the spike protein of SARS-CoV-2, the virus that causes Covid-19

UNB/Xinhua
26 August, 2020, 01:45 pm
Last modified: 26 August, 2020, 01:51 pm
Photo: Xinhua via UNB
Photo: Xinhua via UNB

China has approved the human trial of a new Covid-19 vaccine produced by using insect cells, said Chinese officials.

Vaccine developers at the West China Hospital of Sichuan University Monday said the recombinant protein vaccine was issued with a clinical research permit from the National Medical Products Administration, reports Xinhua.

According to researchers, it will be China's first Covid-19 vaccine candidate grown in insect cells for humans.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

The vaccine is designed to trigger antibodies against specific areas on the spike protein of SARS-CoV-2, the virus that causes Covid-19.

China's Sinovac enters supply deal with Indonesia for Covid-19 vaccine doses

The results of animal tests were published in the journal Nature on July 29, which showed that the vaccine could induce immune responses against SARS-CoV-2 infection in mice, rabbits and non-human primates as early as seven or 14 days after a single dose injection, with 'no obvious' side effects.

Co-author Wei Yuquan, a senior researcher of the hospital's state key laboratory of biotherapy, said the vaccine was produced by inserting genes of the SARS-CoV-2 virus into insect cell cultures, which can grow viral proteins.

Such an approach is suitable for large-scale manufacturing of vaccines.

Scientists have previously used insect cells to develop recombinant vaccines against cervical cancer and influenza in Western countries, said Wei, adding that the approach can be safely used on humans.

The Chengdu-based hospital is also cooperating with a local company to design a vaccine production line.

Top News

China / Vaccine / Insect

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Inflation, exchange rate shocks to intensify fiscal pressure in FY26
    Inflation, exchange rate shocks to intensify fiscal pressure in FY26
  • File photo of jamaat leader ATM Azharul Islam
    ATM Azharul Islam set free after acquittal in war crimes case
  • Google Pay. Photo: Collected
    Google Pay likely coming to Bangladesh soon

MOST VIEWED

  • Selim RF Hussain. Sketch: TBS
    BRAC Bank MD Selim RF Hussain resigns
  • Bangladesh Bank Governor Ahsan H Mansur. TBS Sketch
    Depositors need not worry as govt will take over banks before merger: BB governor
  • Graphics: TBS
    Suspicious banking activities surge by 56% since July: Cenbank
  • Photo: Collected
    DU student assaulted for protesting eve-teasing at Chadni Chowk
  • Illustration: TBS
    Bangladesh sees highest-ever per capita income of $2,820 in FY25, BBS provisional data shows
  • Officials protest inside the Secretariat on Tuesday, 27 May 2025, over a government ordinance amending the Public Service Act, 2018. Photo: Rajib Dhar
    Protest at Secretariat suspended as govt assures decision on ordinance tomorrow

Related News

  • Mango exports to China begins tomorrow
  • Weak Chinese demand leaves Australia with too much wheat
  • China explores cross-border trade cooperation with Bangladesh
  • Govt plans to relocate country's first vaccine plant from Gopalganj to Munshiganj
  • Dhaka, Beijing seek to resolve deadlock over dollar loan terms at JEC talks

Features

In recent years, the Gor-e-Shaheed Eidgah has emerged as a strong contender for the crown of the biggest Eid congregation in the country, having hosted 600,000 worshippers in 2017. Photo: TBS

Gor-e-Shaheed Boro Maath: The heart of Dinajpur

1d | Panorama
The Hili Land Port, officially opened in 1997 but with trade roots stretching back to before Partition, has grown into a cornerstone of bilateral commerce.

Dhaka-Delhi tensions ripple across Hili’s markets and livelihoods

2d | Panorama
Photo: Collected

Desk goals: Affordable ways to elevate your study setup

2d | Brands
Built on a diamond-type frame, the Hornet 2.0 is agile but grounded. PHOTO: Asif Chowdhury

Honda Hornet 2.0: Same spirit, upgraded sting

2d | Wheels

More Videos from TBS

How protecting Dhaka’s rivers and canals from plastic waste

How protecting Dhaka’s rivers and canals from plastic waste

33m | TBS Programs
Jamaat leader ATM Azhar released from prison after 13 years

Jamaat leader ATM Azhar released from prison after 13 years

53m | TBS Today
Trump delays 50% tariffs on EU goods

Trump delays 50% tariffs on EU goods

11h | Others
Eid may be celebrated in Bangladesh on June 7

Eid may be celebrated in Bangladesh on June 7

11h | TBS Today
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net